{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:48Z","timestamp":1792784928670,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973334"],"award-info":[{"award-number":["81973334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773702"],"award-info":[{"award-number":["81773702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Innovation of Science and Technology-2030 (Program of Brain Science and Brain-Inspired Intelligence Technology) Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Substance use disorder remains a major challenge, with an enduring need to identify and evaluate new, translational targets for effective treatment. Here, we report the upregulation of Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) expression by roxadustat (Rox), a drug developed for renal anemia that inhibits HIF prolyl hydroxylase to prevent degradation of HIF-1\u03b1, administered either systemically or locally into selected brain regions, suppressed morphine (Mor)-induced conditioned place preference (CPP). A similar effect was observed with methamphetamine (METH). Moreover, Rox also inhibited the expression of both established and reinstated Mor-CPP and promoted the extinction of Mor-CPP. Additionally, the elevation of HIF-1\u03b1 enhanced hepcidin\/ferroportin 1 (FPN1)-mediated iron efflux and resulted in cellular iron deficiency, which led to the functional accumulation of the dopamine transporter (DAT) in plasma membranes due to iron deficiency-impaired ubiquitin degradation. Notably, iron-deficient mice generated via a low iron diet mimicked the effect of Rox on the prevention of Mor- or METH-CPP formation, without affecting other types of memory. These data reveal a novel mechanism for HIF-1\u03b1 and iron involvement in substance use disorder, which may represent a potential novel therapeutic strategy for the treatment of drug abuse. The findings also repurpose Rox by suggesting a potential new indication for the treatment of substance use disorder.<\/jats:p>","DOI":"10.1038\/s41392-023-01578-2","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T20:01:41Z","timestamp":1694980901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis"],"prefix":"10.1038","volume":"8","author":[{"given":"Pengju","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuliu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longtai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechu","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","volume":"2","author":"EJ Nestler","year":"2001","unstructured":"Nestler, E. J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119\u2013128 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"1578_CR2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","volume":"376","author":"M Soyka","year":"2017","unstructured":"Soyka, M. Treatment of benzodiazepine dependence. N. Engl. J. Med. 376, 1147\u20131157 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1578_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157015911795017245","volume":"9","author":"SF Ali","year":"2011","unstructured":"Ali, S. F. et al. Understanding the global problem of drug addiction is a challenge for idars scientists. Curr. Neuropharmacol. 9, 2\u20137 (2011).","journal-title":"Curr. Neuropharmacol."},{"key":"1578_CR4","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1096\/fj.12-218727","volume":"27","author":"WC Hong","year":"2013","unstructured":"Hong, W. C. & Amara, S. G. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or pkc-regulated endocytosis in dopamine neurons. FASEB J 27, 2995\u20133007 (2013).","journal-title":"FASEB J"},{"key":"1578_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02087-x","volume":"8","author":"DO Sambo","year":"2017","unstructured":"Sambo, D. O. et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat. Commun. 8, 2228 (2017).","journal-title":"Nat. Commun."},{"key":"1578_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson, S. W. & North, R. A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483\u2013488 (1992).","journal-title":"J. Neurosci."},{"key":"1578_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","volume":"38","author":"HL Fields","year":"2015","unstructured":"Fields, H. L. & Margolis, E. B. Understanding opioid reward. Trends Neurosci 38, 217\u2013225 (2015).","journal-title":"Trends Neurosci"},{"key":"1578_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pnpbp.2014.11.010","volume":"58","author":"EA Marinho","year":"2015","unstructured":"Marinho, E. A. et al. Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 58, 22\u201331 (2015).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1578_CR9","doi-asserted-by":"crossref","first-page":"101109","DOI":"10.1016\/j.redox.2019.101109","volume":"25","author":"HS Li","year":"2019","unstructured":"Li, H. S. et al. HIF-1\u03b1 protects against oxidative stress by directly targeting mitochondria. Redox Biol 25, 101109 (2019).","journal-title":"Redox Biol"},{"key":"1578_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2008.05.002","volume":"395","author":"S Kaluz","year":"2008","unstructured":"Kaluz, S., Kaluzov\u00e1, M. & Stanbridge, E. J. Regulation of gene expression by hypoxia: Integration of the hif-transduced hypoxic signal at the hypoxia-responsive element. Clin. Chim. Acta 395, 6\u201313 (2008).","journal-title":"Clin. Chim. Acta"},{"key":"1578_CR11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/aps.2010.132","volume":"31","author":"D Tekin","year":"2010","unstructured":"Tekin, D., Dursun, A. D. & Xi, L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol. Sin. 31, 1085\u20131094 (2010).","journal-title":"Acta Pharmacol. Sin."},{"key":"1578_CR12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jclinpath-2012-200828","volume":"65","author":"L Gao","year":"2012","unstructured":"Gao, L., Chen, Q., Zhou, X. & Fan, L. The role of hypoxia-inducible factor 1 in atherosclerosis. J. Clin. Pathol. 65, 872\u2013876 (2012).","journal-title":"J. Clin. Pathol."},{"key":"1578_CR13","first-page":"e90427","volume":"2","author":"PI Chen","year":"2017","unstructured":"Chen, P. I. et al. Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension. JCI insight 2, e90427 (2017).","journal-title":"JCI insight"},{"key":"1578_CR14","doi-asserted-by":"crossref","first-page":"108540","DOI":"10.1016\/j.exer.2021.108540","volume":"206","author":"M Lee","year":"2021","unstructured":"Lee, M., Leskova, W., Eshaq, R. S. & Harris, N. R. Retinal hypoxia and angiogenesis with methamphetamine. Exp. Eye Res. 206, 108540 (2021).","journal-title":"Exp. Eye Res."},{"key":"1578_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/WNR.0b013e32834d0bc8","volume":"22","author":"SM Kousik","year":"2011","unstructured":"Kousik, S. M., Graves, S. M., Napier, T. C., Zhao, C. & Carvey, P. M. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport 22, 923\u2013928 (2011).","journal-title":"Neuroreport"},{"key":"1578_CR16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","volume":"177","author":"L Koodie","year":"2010","unstructured":"Koodie, L., Ramakrishnan, S. & Roy, S. Morphine suppresses tumor angiogenesis through a HIF-1alpha\/p38MAPK pathway. Am. J. Pathol. 177, 984\u2013997 (2010).","journal-title":"Am. J. Pathol."},{"key":"1578_CR17","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1006\/jmcc.2001.1480","volume":"33","author":"S Balasubramanian","year":"2001","unstructured":"Balasubramanian, S. et al. Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J. Mol. Cell. Cardiol. 33, 2179\u20132187 (2001).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1578_CR18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.21037\/jgo-20-394","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Jiang, L., Wang, J., Chai, Z. & Xiong, W. Morphine promotes angiogenesis by activating PI3K\/AKT\/HIF-1\u03b1 pathway and upregulating vegf in hepatocellular carcinoma. J. Gastrointest. Oncol. 12, 1761\u20131772 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"1578_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellimm.2010.08.002","volume":"265","author":"JL Martin","year":"2010","unstructured":"Martin, J. L., Charboneau, R., Barke, R. A. & Roy, S. Chronic morphine treatment inhibits lps-induced angiogenesis: Implications in wound healing. Cell. Immunol. 265, 139\u2013145 (2010).","journal-title":"Cell. Immunol."},{"key":"1578_CR20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1067\/msy.2003.247","volume":"134","author":"S Roy","year":"2003","unstructured":"Roy, S. et al. Morphine inhibits vegf expression in myocardial ischemia. Surgery 134, 336\u2013344 (2003).","journal-title":"Surgery"},{"key":"1578_CR21","first-page":"598","volume":"69","author":"MM Xu","year":"2017","unstructured":"Xu, M. M., Wang, J. & Xie, J. X. Regulation of iron metabolism by hypoxia-inducible factors. Acta Physiol. Sinica 69, 598\u2013610 (2017).","journal-title":"Acta Physiol. Sinica"},{"key":"1578_CR22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neuropharm.2013.10.024","volume":"77","author":"G Rathnasamy","year":"2014","unstructured":"Rathnasamy, G., Ling, E. A. & Kaur, C. Hypoxia inducible factor-1\u03b1 mediates iron uptake which induces inflammatory response in amoeboid microglial cells in developing periventricular white matter through map kinase pathway. Neuropharmacology 77, 428\u2013440 (2014).","journal-title":"Neuropharmacology"},{"key":"1578_CR23","first-page":"6286984","volume":"2020","author":"X Li","year":"2020","unstructured":"Li, X. et al. Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via akt\/gsk-3\u03b2\/nrf2 pathway. Oxid. Med. Cell. Longev. 2020, 6286984 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1578_CR24","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1002\/jcp.27188","volume":"234","author":"M Xu","year":"2019","unstructured":"Xu, M. et al. Differential regulation of estrogen in iron metabolism in astrocytes and neurons. J. Cell. Physiol. 234, 4232\u20134242 (2019).","journal-title":"J. Cell. Physiol."},{"key":"1578_CR25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/o69-160","volume":"47","author":"AL Symes","year":"1969","unstructured":"Symes, A. L., Sourkes, T. L., Youdim, M. B., Gregoriadis, G. & Birnbaum, H. Decreased monoamine oxidase activity in liver of iron-deficient rats. Can. J. Biochem. 47, 999\u20131002 (1969).","journal-title":"Can. J. Biochem."},{"key":"1578_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1079\/PNS19780022","volume":"37","author":"MB Youdim","year":"1978","unstructured":"Youdim, M. B. & Green, A. R. Iron deficiency and neurotransmitter synthesis and function. Proc. Nutr. Soc. 37, 173\u2013179 (1978).","journal-title":"Proc. Nutr. Soc."},{"key":"1578_CR27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jnutbio.2014.07.003","volume":"25","author":"J Kim","year":"2014","unstructured":"Kim, J. & Wessling-Resnick, M. Iron and mechanisms of emotional behavior. J. Nutr. Biochem. 25, 1101\u20131107 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"1578_CR28","doi-asserted-by":"crossref","first-page":"e1040","DOI":"10.1038\/tp.2016.271","volume":"7","author":"KD Ersche","year":"2017","unstructured":"Ersche, K. D. et al. Disrupted iron regulation in the brain and periphery in cocaine addiction. Transl. Psychiat. 7, e1040 (2017).","journal-title":"Transl. Psychiat."},{"key":"1578_CR29","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/WNR.0b013e3282f0d4f4","volume":"18","author":"WP Melega","year":"2007","unstructured":"Melega, W. P., La\u0107an, G., Harvey, D. C. & Way, B. M. Methamphetamine increases basal ganglia iron to levels observed in aging. Neuroreport 18, 1741\u20131745 (2007).","journal-title":"Neuroreport"},{"key":"1578_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02786262","volume":"54","author":"T Elnimr","year":"1996","unstructured":"Elnimr, T., Hashem, A. & Assar, R. Heroin dependence effects on some major and trace elements. Biol. Trace Elem. Res. 54, 153\u2013162 (1996).","journal-title":"Biol. Trace Elem. Res."},{"key":"1578_CR31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ADM.0000000000000134","volume":"9","author":"A Akbari","year":"2015","unstructured":"Akbari, A. et al. Serum zinc, copper, iron, and magnesium levels in iranian drug users: A case control study. J. Addict. Med. 9, 304\u2013307 (2015).","journal-title":"J. Addict. Med"},{"key":"1578_CR32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41401-021-00806-1","volume":"43","author":"PJ Yan","year":"2022","unstructured":"Yan, P. J. et al. Dysregulation of iron homeostasis and methamphetamine reward behaviors in clk1-deficient mice. Acta Pharmacol. Sin. 43, 1686\u20131698 (2022).","journal-title":"Acta Pharmacol. Sin."},{"key":"1578_CR33","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nn1143","volume":"6","author":"CA McClung","year":"2003","unstructured":"McClung, C. A. & Nestler, E. J. Regulation of gene expression and cocaine reward by creb and deltafosb. Nat. Neurosci. 6, 1208\u20131215 (2003).","journal-title":"Nat. Neurosci."},{"key":"1578_CR34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.09.047","volume":"317","author":"SK Nygard","year":"2017","unstructured":"Nygard, S. K., Klambatsen, A., Balouch, B., Quinones-Jenab, V. & Jenab, S. Nmdar dependent intracellular responses associated with cocaine conditioned place preference behavior. Behav. Brain Res. 317, 218\u2013225 (2017).","journal-title":"Behav. Brain Res."},{"key":"1578_CR35","first-page":"176","volume":"103","author":"BP Smyth","year":"2010","unstructured":"Smyth, B. P., Barry, J., Keenan, E. & Ducray, K. Lapse and relapse following inpatient treatment of opiate dependence. Ir. Med. J. 103, 176\u2013179 (2010).","journal-title":"Ir. Med. J."},{"key":"1578_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-10-5562-1_1","volume":"1010","author":"Y Ndasauka","year":"2017","unstructured":"Ndasauka, Y., Wei, Z. & Zhang, X. Received view of addiction, relapse and treatment. Adv. Exp. Med. Biol 1010, 3\u201319 (2017).","journal-title":"Adv. Exp. Med. Biol"},{"key":"1578_CR37","doi-asserted-by":"crossref","first-page":"e09275","DOI":"10.7554\/eLife.09275","volume":"4","author":"M Chen","year":"2015","unstructured":"Chen, M. et al. Morphine disinhibits glutamatergic input to vta dopamine neurons and promotes dopamine neuron excitation. eLife 4, e09275 (2015).","journal-title":"eLife"},{"key":"1578_CR38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/hmg\/ddt007","volume":"22","author":"H Jaaro-Peled","year":"2013","unstructured":"Jaaro-Peled, H. et al. Subcortical dopaminergic deficits in a disc1 mutant model: A study in direct reference to human molecular brain imaging. Hum. Mol. Genet 22, 1574\u20131580 (2013).","journal-title":"Hum. Mol. Genet"},{"key":"1578_CR39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/mds.27133","volume":"32","author":"YY Lai","year":"2017","unstructured":"Lai, Y. Y. et al. Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome. Movement Disord 32, 1687\u20131693 (2017).","journal-title":"Movement Disord"},{"key":"1578_CR40","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.3390\/cancers13215557","volume":"13","author":"A Vall\u00e9e","year":"2021","unstructured":"Vall\u00e9e, A., Lecarpentier, Y. & Vall\u00e9e, J. N. The key role of the wnt\/\u03b2-catenin pathway in metabolic reprogramming in cancers under normoxic conditions. Cancers 13, 5557 (2021).","journal-title":"Cancers"},{"key":"1578_CR41","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92, 5510\u20135514 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1578_CR42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer, N. V. et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12, 149\u2013162 (1998).","journal-title":"Genes Dev"},{"key":"1578_CR43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Targeting hif-1 for cancer therapy. Nat. Rev. Cancer 3, 721\u2013732 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"1578_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee, J. W., Bae, S. H., Jeong, J. W., Kim, S. H. & Kim, K. W. Hypoxia-inducible factor (hif-1)alpha: Its protein stability and biological functions. Exp. Mol. Med. 36, 1\u201312 (2004).","journal-title":"Exp. Mol. Med."},{"key":"1578_CR45","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","volume":"8","author":"GL Semenza","year":"2002","unstructured":"Semenza, G. L. Hif-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol. Med. 8, S62\u2013S67 (2002).","journal-title":"Trends Mol. Med."},{"key":"1578_CR46","first-page":"E2516","volume":"113","author":"G Hoppe","year":"2016","unstructured":"Hoppe, G. et al. Comparative systems pharmacology of hif stabilization in the prevention of retinopathy of prematurity. Proc. Natl. Acad. Sci. USA. 113, E2516\u2013E2525 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1578_CR47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.ajkd.2015.12.020","volume":"67","author":"R Provenzano","year":"2016","unstructured":"Provenzano, R. et al. Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: A phase 2, randomized, 6- to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am. J. Kidney Dis. 67, 912\u2013924 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"1578_CR48","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.drudis.2020.04.017","volume":"25","author":"K Su","year":"2020","unstructured":"Su, K., Li, Z., Yu, Y. & Zhang, X. The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia. Drug Discov. Today 25, 1262\u20131269 (2020).","journal-title":"Drug Discov. Today"},{"key":"1578_CR49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13311-019-00807-3","volume":"17","author":"G Li","year":"2020","unstructured":"Li, G. et al. FG-4592 improves depressive-like behaviors through hif-1-mediated neurogenesis and synapse plasticity in rats. Neurotherapeutics 17, 664\u2013675 (2020).","journal-title":"Neurotherapeutics"},{"key":"1578_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","volume":"10","author":"X Li","year":"2018","unstructured":"Li, X. et al. Therapeutic potential of a prolyl hydroxylase inhibitor fg-4592 for parkinson\u2019s diseases in vitro and in vivo: Regulation of redox biology and mitochondrial function. Front. Aging Neurosci. 10, 121 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"1578_CR51","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1021\/acschemneuro.9b00539","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Liproxstatin-1 attenuates morphine tolerance through inhibiting spinal ferroptosis-like cell death. ACS Chemi. Neurosci. 10, 4824\u20134833 (2019).","journal-title":"ACS Chemi. Neurosci."},{"key":"1578_CR52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00109-022-02254-8","volume":"100","author":"K Ferrao","year":"2022","unstructured":"Ferrao, K., Ali, N. & Mehta, K. J. Iron and iron-related proteins in alcohol consumers: Cellular and clinical aspects. J. Mol. Med. 100, 1673\u20131689 (2022).","journal-title":"J. Mol. Med."},{"key":"1578_CR53","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/nu14204223","volume":"14","author":"R Bradley","year":"2022","unstructured":"Bradley, R. et al. Fetal alcohol spectrum disorder and iron homeostasis. Nutrients 14, 4223 (2022).","journal-title":"Nutrients"},{"key":"1578_CR54","first-page":"579","volume":"4","author":"V Adisetiyo","year":"2019","unstructured":"Adisetiyo, V. et al. Elevated brain iron in cocaine use disorder as indexed by magnetic field correlation imaging. Biol. Psychiat-Cogn. N. 4, 579\u2013588 (2019).","journal-title":"Biol. Psychiat-Cogn. N."},{"key":"1578_CR55","doi-asserted-by":"crossref","first-page":"0219","DOI":"10.1523\/ENEURO.0237-19.2019","volume":"6","author":"B Nash","year":"2019","unstructured":"Nash, B. et al. Morphine-induced modulation of endolysosomal iron mediates upregulation of ferritin heavy chain in cortical neurons. eNeuro 6, 0219\u20130237 (2019).","journal-title":"eNeuro"},{"key":"1578_CR56","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41401-021-00821-2","volume":"43","author":"B Hempel","year":"2022","unstructured":"Hempel, B. & Xi, Z. X. Mitochondrial clk1-iron-dat regulation pathway: A possible new therapeutic target for methamphetamine use disorder. Acta Pharmacol. Sin. 43, 1887\u20131888 (2022).","journal-title":"Acta Pharmacol. Sin."},{"key":"1578_CR57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2018-06-815894","volume":"133","author":"CY Wang","year":"2019","unstructured":"Wang, C. Y. & Babitt, J. L. Liver iron sensing and body iron homeostasis. Blood 133, 18\u201329 (2019).","journal-title":"Blood"},{"key":"1578_CR58","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.3390\/ijms22126493","volume":"22","author":"E Nemeth","year":"2021","unstructured":"Nemeth, E. & Ganz, T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int. J. Mol. Sci. 22, 6493 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1578_CR59","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090\u20132093 (2004).","journal-title":"Science"},{"key":"1578_CR60","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","volume":"122","author":"Q Liu","year":"2012","unstructured":"Liu, Q., Davidoff, O., Niss, K. & Haase, V. H. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J. Clin. Invest. 122, 4635\u20134644 (2012).","journal-title":"J. Clin. Invest."},{"key":"1578_CR61","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","volume":"117","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux, C. et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (hifs). J. Clin. Invest. 117, 1926\u20131932 (2007).","journal-title":"J. Clin. Invest."},{"key":"1578_CR62","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","volume":"110","author":"G Nicolas","year":"2002","unstructured":"Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037\u20131044 (2002).","journal-title":"J. Clin. Invest."},{"key":"1578_CR63","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1182\/blood-2011-01-330241","volume":"118","author":"DL Zhang","year":"2011","unstructured":"Zhang, D. L. et al. Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood 118, 2868\u20132877 (2011).","journal-title":"Blood"},{"key":"1578_CR64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00427441","volume":"84","author":"HO Pettit","year":"1984","unstructured":"Pettit, H. O., Ettenberg, A., Bloom, F. E. & Koob, G. F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84, 167\u2013173 (1984).","journal-title":"Psychopharmacology"},{"key":"1578_CR65","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nn.4060","volume":"18","author":"S Zhu","year":"2015","unstructured":"Zhu, S. et al. Identification of a vav2-dependent mechanism for gdnf\/ret control of mesolimbic dat trafficking. Nat. Neurosci. 18, 1084\u20131093 (2015).","journal-title":"Nat. Neurosci."},{"key":"1578_CR66","volume":"7","author":"Y Mu","year":"2014","unstructured":"Mu, Y. et al. Inhibition of phosphodiesterase10a attenuates morphine-induced conditioned place preference. Mol. Brain 7, 70 (2014).","journal-title":"Mol. Brain"},{"key":"1578_CR67","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fphar.2020.00476","volume":"11","author":"X Shen","year":"2020","unstructured":"Shen, X. et al. Berberine facilitates extinction of drug-associated behavior and inhibits reinstatement of drug seeking. Front. Pharmacol. 11, 476 (2020).","journal-title":"Front. Pharmacol."},{"key":"1578_CR68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00277-004-0945-9","volume":"84","author":"AH Laftah","year":"2005","unstructured":"Laftah, A. H. et al. Effect of altered iron metabolism on markers of haem biosynthesis and intestinal iron absorption in mice. Ann. Hematol. 84, 177\u2013182 (2005).","journal-title":"Ann. Hematol."},{"key":"1578_CR69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2004.03.015","volume":"152","author":"DY Ryu","year":"2004","unstructured":"Ryu, D. Y. et al. Dietary iron regulates intestinal cadmium absorption through iron transporters in rats. Toxicol. Lett. 152, 19\u201325 (2004).","journal-title":"Toxicol. Lett."},{"key":"1578_CR70","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3945\/jn.109.112557","volume":"139","author":"P Dowling","year":"2009","unstructured":"Dowling, P., Klinker, F., Amaya, F., Paulus, W. & Liebetanz, D. Iron-deficiency sensitizes mice to acute pain stimuli and formalin-induced nociception. J. Nutr. 139, 2087\u20132092 (2009).","journal-title":"J. Nutr."},{"key":"1578_CR71","volume":"8","author":"H Zhou","year":"2017","unstructured":"Zhou, H. et al. The interhemispheric ca1 circuit governs rapid generalisation but not fear memory. Nat. Commun. 8, 2190 (2017).","journal-title":"Nat. Commun."},{"key":"1578_CR72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2016.10.018","volume":"60","author":"R Gu","year":"2017","unstructured":"Gu, R. et al. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming. Brain. Behav. Immun. 60, 206\u2013219 (2017).","journal-title":"Brain. Behav. Immun."},{"key":"1578_CR73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2015.04.014","volume":"49","author":"J Ni","year":"2015","unstructured":"Ni, J. et al. Microrna let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain. Behav. Immun. 49, 75\u201385 (2015).","journal-title":"Brain. Behav. Immun."},{"key":"1578_CR74","doi-asserted-by":"crossref","first-page":"107675","DOI":"10.1016\/j.neuropharm.2019.107675","volume":"157","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. D2 receptor-mediated mirna-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with neuregulin-1 expression in mice. Neuropharmacology 157, 107675 (2019).","journal-title":"Neuropharmacology"},{"key":"1578_CR75","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41589-019-0371-x","volume":"15","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Axonal iron transport in the brain modulates anxiety-related behaviors. Nat. Chem. Biol. 15, 1214\u20131222 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1578_CR76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1471-4159.2006.04175.x","volume":"100","author":"JA Wiesinger","year":"2007","unstructured":"Wiesinger, J. A. et al. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis. J. Neurochem. 100, 167\u2013179 (2007).","journal-title":"J. Neurochem"},{"key":"1578_CR77","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/aps.2013.66","volume":"34","author":"X Fang","year":"2013","unstructured":"Fang, X. et al. Skf83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity. Acta Pharmacol. Sin. 34, 1149\u20131155 (2013).","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01578-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T18:03:57Z","timestamp":1700589837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01578-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01578-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>:<\/b> The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}